Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors
about
The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitroA heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transferTherapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver diseaseResistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response.Progress in cancer gene therapy.In situ use of suicide genes for therapy of brain tumours.Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.Prodrug activation enzymes in cancer gene therapy.Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disordersPhase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.Membrane repair and immunological danger.In situ gene therapy for prostate cancer: immunomodulatory approaches.Gene therapy for high grade gliomas.Combination gene therapy for liver metastasis of colon carcinoma in vivoCombined suicide and cytokine gene therapy for peritoneal carcinomatosisEnhanced central memory cluster of differentiation 8(+) and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy.Gene therapy for thyroid cancer.Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses.Genetic strategies for brain tumor therapy.Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas.Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response.The controversial role of microglia in malignant gliomas.A candidate live inactivatable attenuated vaccine for AIDS.Increased anti-tumor effect by a combination of HSV thymidine kinase suicide gene therapy and interferon-gamma/GM-CSF cytokine gene therapy in CT26 tumor model.Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.Immune and viral therapies for malignant primary brain tumors.Bystander-mediated regression of murine neuroblastoma via retroviral transfer of the HSV-TK gene.Ganciclovir and penciclovir, but not acyclovir, induce apoptosis in herpes simplex virus thymidine kinase-transformed baby hamster kidney cells.Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens.Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials.Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.Applications of gene therapy to the CNS.Gene therapy for neurologic disease: benchtop discoveries to bedside applications. 1. The bench.Current status of gene therapy for prostate and bladder cancer.The promise and reality of cancer gene therapy.Gene- and viral-based therapies for brain tumorsA general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase.Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.Replicative retroviral vectors for cancer gene therapy.Effects of retroviral-mediated herpes simplex virus thymidine kinase gene transfer to murine neuroblastoma cell lines in vitro and in vivo.
P2860
Q24564192-BD70AFB7-03A2-49D9-A203-4BF226EF9B81Q24616181-1E8EC477-B4CD-42E8-B67C-92C020145379Q28472958-A24F8640-E26F-4A5B-9C7F-394D0301573AQ33221445-3CDDC2BE-8EE3-4468-AE8B-6DAACDD027DEQ33752288-644DE43D-83BC-4E75-BA2C-66B9EC331F21Q33841658-97F93546-B476-450B-ABBA-CBB81D6612A2Q33873085-99003FAE-09F1-429A-8995-75A721F0007EQ33968115-E8801A6C-55E9-494B-879F-031CB2DC4A29Q33985663-48153BDA-9AA9-4EBF-AB7D-8C95FD860158Q34208293-0B042034-FA27-4052-A91C-CFC0AE86CFEBQ34360555-9480704F-F8D4-418A-BC1C-73F5D30A875DQ34452001-7653CB94-3F8B-4458-BABB-68CFD639CF53Q34452062-8D864DE7-5B21-45F9-80C6-63FD025BD757Q34480736-1E0E9435-774F-400E-B61F-4FEE853EA39CQ35361079-916FC419-E0B0-414B-90AE-34617888C478Q35753616-7B2DEBC9-0E94-4917-8965-AA90E2A0132DQ35842601-7560DB88-269F-4294-B35F-940554CE2CB1Q35851094-B94C5AD3-0C9A-43BE-BF97-DE0C1AB5DE47Q36247099-7D77507D-E30B-46E2-A03B-59CDED346368Q36367428-6766FEEE-1BBF-4F6E-A1CD-2201E1168AFBQ36659314-2D23CAFF-5A95-472D-94B4-F497C4579E90Q37091110-3FEEAF18-6E3C-4518-B89D-3A2FB185610FQ37364176-CF5B52F3-CCF8-4C71-959D-A45234A5667AQ37425821-F9EBD24D-B61D-4A89-AF21-365E62C40954Q37861631-3666BC03-F016-45B8-AC2A-3915A1CEA872Q39168899-9DF02774-847B-4BC5-AE42-C36EA96B2319Q40589509-468A3ABF-E02A-41C1-9A12-4B51DED1E111Q40637172-C49B4398-2C5E-4B22-9B5C-6A183911E28BQ40761219-1C28D0A9-6DAD-48F2-9811-E4DA4E4BEC9AQ40790899-7A368488-4A12-44C2-BC5B-CAE8E3F062A9Q40937528-FFFC920F-70F8-4245-ADF0-B88AC0AF9C05Q40957115-86DFD074-67C9-4505-BC40-3BBF63041DFDQ41332176-D2A95617-F8DF-4DF3-844E-68685361A877Q41631041-F9B0644D-59B8-4DB4-8B59-4ED8838D7CEDQ41650537-1815C807-105C-48A5-993E-6BB697A4D9E3Q42135456-3E68F71A-576B-4AB2-B0DC-15496063F63AQ42359931-2E9AEBB9-93A5-4A23-906C-CA8B3AB73526Q42360056-C4B207E7-06EA-47E5-A1D2-0EF9367D0D96Q42807227-E6354A58-FDBA-49F8-8C9B-987349EDBC5DQ43408983-9CD7B56D-CF3C-48ED-99CA-E82D927334E7
P2860
Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Development of anti-tumor immu ...... g of experimental brain tumors
@ast
Development of anti-tumor immu ...... g of experimental brain tumors
@en
type
label
Development of anti-tumor immu ...... g of experimental brain tumors
@ast
Development of anti-tumor immu ...... g of experimental brain tumors
@en
prefLabel
Development of anti-tumor immu ...... g of experimental brain tumors
@ast
Development of anti-tumor immu ...... g of experimental brain tumors
@en
P2093
P2860
P356
P1476
Development of anti-tumor immu ...... g of experimental brain tumors
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.10.4348
P407
P577
1994-05-01T00:00:00Z